Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 85.60
0.00 (0.00%)
Oct 21, 2026, 5:24 PM IDT
TLV:IMED Revenue
Imed Infinity Medical-Limited Partnership had revenue of $14.00K USD in the half year ending June 30, 2026. This brings the company's total for the last twelve months to $-417.00K. In the year 2025, Imed Infinity Medical-Limited Partnership had annual revenue of $226.00K with 451.22% growth. That makes Imed Infinity Medical-Limited Partnership the 48,102nd largest company in the world by revenue and 458th in Israel.
Revenue (ttm)
$-417.00K
Revenue Growth
+451.22%
P/S Ratio
n/a
Revenue / Employee
$-3.48K
Employees
120
Market Cap
6.52M ILS
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 226.00K | 185.00K | 451.22% |
| Dec 31, 2024 | 41.00K | 983.00K | - |
| Dec 31, 2023 | -942.00K | -1.14M | - |
| Dec 31, 2022 | 200.00K | 125.00K | 166.67% |
| Dec 31, 2021 | 75.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Rafa Laboratories | 459.86M |
| BrainsWay | 180.82M |
| Bio-View | 20.70M |
| Evogene | 4.94M |
| Can-Fite BioPharma | 1.21M |
| Storage Drop Storage Technologies | 31.00K |